Activation of mitogenic pathways and sensitization to estrogen-induced apoptosis: two independent characteristics of tamoxifen-resistant breast cancer cells? Alexander M. ScherbakovYulia S. LobanovaMikhail A. Krasil’nikov Preclinical study 20 September 2006 Pages: 1 - 11
GnRH analogs reduce invasiveness of human breast cancer cells Julia von AltenStefanie FisterCarsten Gründker Preclinical Study 07 June 2006 Pages: 13 - 21
Assessment of multiple different estrogen receptor-β antibodies for their ability to immunoprecipitate under chromatin immunoprecipitation conditions Gregory E. WeitsmanGeorge SklirisLeigh C. Murphy Preclinical study 17 May 2006 Pages: 23 - 31
Proteasome Inhibitors Induce a p38 Mitogen-activated Protein Kinase (MAPK)-dependent Anti-apoptotic Program Involving MAPK Phosphatase-1 and Akt in Models of Breast Cancer Yue Y. ShiGeorge W. SmallRobert Z. Orlowski Preclinical Study 29 June 2006 Pages: 33 - 47
Secreted Frizzled Related Protein 2 (sFRP2) Decreases Susceptibility to UV-Induced Apoptosis in Primary Culture of Canine Mammary Gland Tumors by NF-κB Activation or JNK Suppression Jia-Lin LeeChing-Jin ChangChung-Tien Lin Preclinical Study 22 June 2006 Pages: 49 - 58
Premature Menopause in Patients with BRCA1 Gene Mutation Izabella Rzepka-GórskaBogusław TarnowskiAleksandra Tołoczko-Grabarek Clinical Trial 14 June 2006 Pages: 59 - 63
Cosmetic outcomes following breast conservation therapy: in search of a reliable scale Amanda J. FortinMary CheangSteven Latosinsky CLINICAL STUDY 04 July 2006 Pages: 65 - 70
Estrogen Receptor Expression in Benign Breast Ductal Cells Obtained from Random Periareolar Fine Needle Aspiration Correlates with Menopausal Status and Cytomorphology Index Score Priyanka SharmaBruce F. KimlerCarol J. Fabian Clinical trial 22 June 2006 Pages: 71 - 76
Intensity of diagnostic and treatment activities during the end of life of patients with advanced breast cancer R. AsolaH. HuhtalaK. Holli Epidemiology 07 June 2006 Pages: 77 - 82
Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families Giuseppe GianniniCarlo CapalboAlberto Gulino Epidemiology 09 May 2006 Pages: 83 - 91
Interaction of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferase M1 to breast cancer in Taiwanese woman without smoking and drinking habits Szu-Hsien WuShih-Meng TsaiLi-Yu Tsai Epidemiology 07 June 2006 Pages: 93 - 98
CHEK2 1100delC mutation is frequent among Russian breast cancer patients Elena V. ChekmariovaAnna P. SokolenkoEvgeny N. Imyanitov Epidemiology 07 June 2006 Pages: 99 - 102
Genetic determinants of bone mass do not relate with breast cancer risk in US white and African-American women Pamela J. VandeVordPaul H. WooleyDorothy A. Nelson Epidemiology 22 June 2006 Pages: 103 - 107
Factors Affecting Sensitivity and Specificity of Screening Mammography and MRI in Women with an Inherited Risk for Breast Cancer Mieke KriegeCecile T. M. BrekelmansJan G. M. Klijn Epidemiology 22 June 2006 Pages: 109 - 119
Effects of Estrogen Receptor Expression and Histopathology on Annual Hazard Rates of Death from Breast Cancer William F. AndersonBingshu E. ChenPhilip S. Rosenberg Original Report 10 May 2006 Pages: 121 - 126